FDA approves app-based remote monitoring system for patients with implantable pacemakers

Tim Casey | | Cardiovascular Business | Remote Monitoring

On Nov. 17, the FDA approved the MyCareLink Smart Monitor, the first app-based remote monitoring system in the U.S. for patients with implantable pacemakers.

Medtronic manufactures the system, which is compatible with the company’s pacemakers. The system includes a handheld portable device reader that is prescribed by a physician and a mobile app that is available for free on Android and Apple platforms.

With the system, patients use their smartphone or tablet to securely transmit data from their pacemakers to their physicians, confirm the date of their most recent transmission, manage pacemaker information and data transmissions and receive email or text reminders, confirmations and notifications of their data transmissions.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Dexcom recalls more than 2 million CGM receivers over safety issues—dozens of adverse events reported
Cuffless blood pressure measurement devices: Convenient, but not ready for clinical use
Duke specialists to detail the benefits of treating heart failure with Barostim
FDA approves new AI-enabled wearable cardioverter defibrillator
Implantable IVC sensor shows early potential to guide heart failure management
Starfish-shaped heart monitors use AI to deliver accurate results

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.